These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17822345)

  • 1. Development and validation of the outburst monitoring scale for children and adolescents.
    Kronenberger WG; Giauque AL; Dunn DW
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):511-26. PubMed ID: 17822345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid ADHD, conduct/oppositional-defiant disorder, and aggression: a prospective, open-label study.
    Kronenberger WG; Giauque AL; Lafata DE; Bohnstedt BN; Maxey LE; Dunn DW
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):334-47. PubMed ID: 17630867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.
    Sinzig J; Döpfner M; Lehmkuhl G; ; Uebel H; Schmeck K; Poustka F; Gerber WD; Günter M; Knölker U; Gehrke M; Hässler F; Resch F; Brünger M; Ose C; Fischer R
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):421-32. PubMed ID: 17822338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 26-week open-label study of quetiapine in children with conduct disorder.
    Findling RL; Reed MD; O'Riordan MA; Demeter CA; Stansbrey RJ; McNamara NK
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):1-9. PubMed ID: 17343549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD.
    Blader JC; Pliszka SR; Jensen PS; Schooler NR; Kafantaris V
    Pediatrics; 2010 Oct; 126(4):e796-806. PubMed ID: 20837589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attendance and Engagement in Parent Training Predict Child Behavioral Outcomes in Children Pharmacologically Treated for Attention-Deficit/Hyperactivity Disorder and Severe Aggression.
    Joseph HM; Farmer C; Kipp H; Kolko D; Aman M; McGinley J; Arnold LE; Gadow KD; Findling RL; Molina BSG
    J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):90-99. PubMed ID: 30592635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children.
    Hazell PL; Stuart JE
    J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):886-94. PubMed ID: 12874489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.
    Gorman DA; Gardner DM; Murphy AL; Feldman M; Bélanger SA; Steele MM; Boylan K; Cochrane-Brink K; Goldade R; Soper PR; Ustina J; Pringsheim T
    Can J Psychiatry; 2015 Feb; 60(2):62-76. PubMed ID: 25886657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.
    Findling RL
    J Clin Psychiatry; 2008; 69 Suppl 4():9-14. PubMed ID: 18533763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder.
    Connor DF; McLaughlin TJ; Jeffers-Terry M
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):140-56. PubMed ID: 18439112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression.
    Rundberg-Rivera EV; Townsend LD; Schneider J; Farmer CA; Molina BB; Findling RL; Gadow KD; Bukstein OG; Arnold LE; Kolko DJ; Buchan-Page KA; McNamara NK; Michel C; Austin A; Kipp H; Rice RR; Aman MG
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):225-33. PubMed ID: 25885012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):52-61. PubMed ID: 25886656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder.
    Farmer CA; Brown NV; Gadow KD; Arnold LE; Kolko DG; Findling RL; Molina BS; Buchan-Page KA; Rice RR; Bangalore SS; Bukstein O; Rundberg-Rivera EV; McNamara N; Aman MG
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):213-24. PubMed ID: 25885011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder?
    Aman MG; Bukstein OG; Gadow KD; Arnold LE; Molina BS; McNamara NK; Rundberg-Rivera EV; Li X; Kipp H; Schneider J; Butter EM; Baker J; Sprafkin J; Rice RR; Bangalore SS; Farmer CA; Austin AB; Buchan-Page KA; Brown NV; Hurt EA; Grondhuis SN; Findling RL
    J Am Acad Child Adolesc Psychiatry; 2014 Jan; 53(1):47-60.e1. PubMed ID: 24342385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conduct behaviors and oppositional defiant behaviors in children and adolescents with ADHD.
    Ghanizadeh A
    Postgrad Med; 2015 Apr; 127(3):289-94. PubMed ID: 25676142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.
    Blader JC; Schooler NR; Jensen PS; Pliszka SR; Kafantaris V
    Am J Psychiatry; 2009 Dec; 166(12):1392-401. PubMed ID: 19884222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development, reliability, and validity of the children's aggression scale-parent version.
    Halperin JM; McKay KE; Newcorn JH
    J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):245-52. PubMed ID: 11886018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.